Amulet IDE Trial Supports Abbott’s New LAA Closure Device

Results of the trial showed Amplatzer Amulet was superior to Boston Scientific’s Watchman for left-atrial appendage closure and noninferior for safety and effectiveness.

Abbott’s Amplatzer Amulet left-atrial appendage (LAA) occluder • Source: Abbott

More from Clinical Trials

More from R&D